Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.30 |
| ▸ | PYGM | P11217 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30770833 | 0.90 | — | — | |
| SCHEMBL9255427 | 0.87 | TDP1 (0.32) | — | |
| SCHEMBL1858435 | 0.83 | SMN1; SMN2 (0.41) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL11430568 | 0.79 | FFAR3 (0.36) | ALDH1A1FFAR3PYGM | |
| SCHEMBL2296442 | 0.79 | — | — | |
| SCHEMBL25337505 | 0.76 | — | — | |
| SCHEMBL28685647 | 0.75 | — | — | |
| SCHEMBL623976 | 0.73 | — | — | |
| SCHEMBL31518852 | 0.69 | PYGM (0.32) | TPMTALDH1A1SMN1; SMN2PYGM | |
| SCHEMBL765594 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014106122-A1 | COMPOSITIONS AND METHODS FOR BIO-BUTADIENE PRODUCTION SCREENING | GENOMATICA, INC. (US) | 2014-07-03 | — | — | WO | disclosed |
| US-20120004476-A1 | Fullerene Derivatives and Organic Electronic Device Comprising the Same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2012-01-05 | — | — | US | disclosed |
| EP-2392555-A2 | FULLERENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | Korea Research Institute of Chemical Technology (KRICT) (KR) | 2011-12-07 | — | — | EP | disclosed |
| WO-2010087655-A2 | FULLERENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | 한국화학연구원 (KR) | 2010-08-05 | — | — | WO | disclosed |
| US-5583261-A | FOR APPLICATION TO PLANTS TO TREAT POWDERY MILDEW | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1996-12-10 | — | — | US | disclosed |
| US-5464873-A | Antigrowth agents | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1995-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004476-A1 | Fullerene Derivatives and Organic Electronic Device Comprising the Same | SCO2, VDAC2, TRPA1 | TPMT 1457/4885ALDH1A1 2704/4885SMN1; SMN2 3736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.